---
title: "董事兼 10% 股東 Jack W. Schuler 報告在 Biodesix 公司中收購普通股"
description: "傑克·W·舒勒（Jack W. Schuler），Biodesix Inc. 的董事及 10% 股東，已報告收購該公司的普通股。完整的文件可通過提供的鏈接獲取。此消息由公共技術公司生成，僅供信息參考，不應視為財務或法律建議。Biodesix Inc. 於 2025 年 9 月 23 日通過 EDGAR 發佈了原始內容"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/258571527.md"
published_at: "2025-09-23T17:06:55.000Z"
---

# 董事兼 10% 股東 Jack W. Schuler 報告在 Biodesix 公司中收購普通股

> 傑克·W·舒勒（Jack W. Schuler），Biodesix Inc. 的董事及 10% 股東，已報告收購該公司的普通股。完整的文件可通過提供的鏈接獲取。此消息由公共技術公司生成，僅供信息參考，不應視為財務或法律建議。Biodesix Inc. 於 2025 年 9 月 23 日通過 EDGAR 發佈了原始內容

傑克·W·舒勒（Jack W. Schuler），一名董事和 10% 的股東，報告了對 Biodesix Inc.普通股的收購。完整的文件可以通過以下鏈接訪問。免責聲明：本新聞簡報由公共技術公司（Public Technologies，PUBT）使用生成性人工智能創建。儘管 PUBT 努力提供準確和及時的信息，但此 AI 生成的內容僅供參考，不應被視為財務、投資或法律建議。Biodesix Inc.通過美國證券交易委員會（U.S. Securities and Exchange Commission）運營的電子數據收集、分析和檢索系統（EDGAR）發佈了用於生成本新聞簡報的原始內容（參考 ID：0000905148-25-003392），並對此信息的內容承擔全部責任。© 版權 2025 - 公共技術公司（PUBT）原始文件：這裏

### Related Stocks

- [BDSX.US - Biodesix](https://longbridge.com/zh-HK/quote/BDSX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Aktionärsgruppe um Sardar Biglari startet Kampagne gegen den Vorstand von Jack in the Box | Sardar Biglari's Biglari Group is launching a "vote no" campaign against the board candidates proposed by Jack in the Bo | [Link](https://longbridge.com/zh-HK/news/275462866.md) |
| Jack in the Box Urges Shareholders to Back Board Amid Activist Challenge | Jack in the Box Inc. is urging shareholders to support its board and vote for all 10 director nominees ahead of the Annu | [Link](https://longbridge.com/zh-HK/news/275462841.md) |
| /C O R R E C T I O N -- Biglari Capital Corp./ \| JACK Stock News | Biglari Capital Corp. has corrected its previous news release urging Jack in the Box shareholders to vote against Chairm | [Link](https://longbridge.com/zh-HK/news/275505067.md) |
| Jack In The Box (JACK) Expected to Announce Earnings on Wednesday | Jack In The Box (NASDAQ:JACK) is set to announce its Q1 2026 earnings on February 18, with expectations of $1.12 per sha | [Link](https://longbridge.com/zh-HK/news/275579491.md) |
| Phibro Animal Health CEO Jack Bendheim Reports Sale of Common Shares | Jack Bendheim, CEO of Phibro Animal Health Corporation, reported the sale of Class A common shares by himself and other  | [Link](https://longbridge.com/zh-HK/news/275672728.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。